Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
20-3
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Abstracts
Index of Authors
Author #28229
advertisement
Chen Y
25
Showing records 1 to 25 |
Display all abstracts from
Chen Y
81413
Discovery and Validation of Circulating Hsa-miR-210-3p as a Potential Biomarker for Primary Open-Angle Glaucoma
Liu Y
Investigative Ophthalmology and Visual Science
2019; 60: 2925-2934
80886
Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axis
Gong B
Genetics in Medicine
2019; 21: 2345-2354
81315
Rapid network meta-analysis using data from Food and Drug Administration approval packages is feasible but with limitations
Wang L; Rouse B
Journal of Clinical Epidemiology
2019; 114: 84-94
80886
Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axis
Zhang H
Genetics in Medicine
2019; 21: 2345-2354
81413
Discovery and Validation of Circulating Hsa-miR-210-3p as a Potential Biomarker for Primary Open-Angle Glaucoma
Wang Y
Investigative Ophthalmology and Visual Science
2019; 60: 2925-2934
80886
Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axis
Huang L
Genetics in Medicine
2019; 21: 2345-2354
81315
Rapid network meta-analysis using data from Food and Drug Administration approval packages is feasible but with limitations
Marks-Anglin A
Journal of Clinical Epidemiology
2019; 114: 84-94
81413
Discovery and Validation of Circulating Hsa-miR-210-3p as a Potential Biomarker for Primary Open-Angle Glaucoma
Chen Y
Investigative Ophthalmology and Visual Science
2019; 60: 2925-2934
81315
Rapid network meta-analysis using data from Food and Drug Administration approval packages is feasible but with limitations
Duan R
Journal of Clinical Epidemiology
2019; 114: 84-94
80886
Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axis
Chen Y
Genetics in Medicine
2019; 21: 2345-2354
81413
Discovery and Validation of Circulating Hsa-miR-210-3p as a Potential Biomarker for Primary Open-Angle Glaucoma
Fang X
Investigative Ophthalmology and Visual Science
2019; 60: 2925-2934
80886
Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axis
Shi Y
Genetics in Medicine
2019; 21: 2345-2354
81413
Discovery and Validation of Circulating Hsa-miR-210-3p as a Potential Biomarker for Primary Open-Angle Glaucoma
Wen T
Investigative Ophthalmology and Visual Science
2019; 60: 2925-2934
81315
Rapid network meta-analysis using data from Food and Drug Administration approval packages is feasible but with limitations
Shi Q; Quach K
Journal of Clinical Epidemiology
2019; 114: 84-94
81413
Discovery and Validation of Circulating Hsa-miR-210-3p as a Potential Biomarker for Primary Open-Angle Glaucoma
Xiao M
Investigative Ophthalmology and Visual Science
2019; 60: 2925-2934
80886
Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axis
Tam PO; Zhu X
Genetics in Medicine
2019; 21: 2345-2354
81315
Rapid network meta-analysis using data from Food and Drug Administration approval packages is feasible but with limitations
Chen Y
Journal of Clinical Epidemiology
2019; 114: 84-94
81413
Discovery and Validation of Circulating Hsa-miR-210-3p as a Potential Biomarker for Primary Open-Angle Glaucoma
Chen S
Investigative Ophthalmology and Visual Science
2019; 60: 2925-2934
81315
Rapid network meta-analysis using data from Food and Drug Administration approval packages is feasible but with limitations
Cameron C
Journal of Clinical Epidemiology
2019; 114: 84-94
80886
Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axis
Huang Y
Genetics in Medicine
2019; 21: 2345-2354
81413
Discovery and Validation of Circulating Hsa-miR-210-3p as a Potential Biomarker for Primary Open-Angle Glaucoma
Zhang X
Investigative Ophthalmology and Visual Science
2019; 60: 2925-2934
81315
Rapid network meta-analysis using data from Food and Drug Administration approval packages is feasible but with limitations
Schmid CH
Journal of Clinical Epidemiology
2019; 114: 84-94
80886
Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axis
Lei B; Sundaresan P
Genetics in Medicine
2019; 21: 2345-2354
81315
Rapid network meta-analysis using data from Food and Drug Administration approval packages is feasible but with limitations
Li T
Journal of Clinical Epidemiology
2019; 114: 84-94
80886
Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axis
Li X; Jiang L; Lin Y; Lu F; Chen L; Li Y; Leung CK; Guo X; Zhang S; Huang G; Wu Y; Zhou T; Shuai P; Tham CC; Weisschuh N; Krishnadas SR; Mardin C; Reis A; Yang J
Genetics in Medicine
2019; 21: 2345-2354
Issue
20-3
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
24-2 (2024)
24-1 (2024)
23-4 (2023)
23-3 (2023)
23-2 (2023)
23-1 (2022)
22-4 (2022)
22-3 (2022)
22-2 (2021)
22-1 (2021)
21-4 (2021)
21-3 (2021)
21-2 (2021)
21-1 (2020)
20-4 (2020)
20-3 (2020)
20-2 (2019)
20-1 (2019)
19-4 (2019)
19-3 (2018)
19-2 (2018)
19-1 (2018)
18-4 (2017)
18-3 (2017)
18-2 (2017)
18-1 (2017)
17-4 (2016)
17-3 (2016)
17-2 (2016)
17-1 (2016)
16-4 (2015)
16-3 (2015)
16-2 (2015)
16-1 (2014)
15-4 (2014)
15-3 (2014)
15-2 (2013)
15-1 (2013)
14-4 (2013)
14-3 (2013)
14-2 (2013)
14-1 (2012)
13-4 (2012)
13-3 (2011)
13-2 (2011)
13-1 (2011)
12-4 (2011)
12-3 (2010)
12-2 (2010)
12-1 (2010)
11-4 (2010)
11-3 (2009)
11-2 (2009)
11-1 (2009)
10-4 (2009)
10-3 (2008)
10-2 (2008)
10-1 (2008)
9-4 (2008)
9-3 (2007)
9-2 (2007)
9-1 (2007)
8-4 (2007)
8-3 (2006)
8-2 (2006)
8-1 (2006)
7-3 (2006)
7-2 (2005)
7-1 (2005)
6-3 (2005)
6-2 (2004)
6-1 (2004)
5-3 (2004)
5-2 (2003)
5-1 (2003)
4-3 (2003)
4-2 (2002)
4-1 (2002)
3-3 (2002)
3-2 (2001)
3-1 (2001)
2-3 (2001)
2-2 (2000)
2-1 (2000)
1-3 (2000)
1-2 (1999)
1-1 (1999)
advertisement